Gene Salkind
CIK: 0001592481
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jul 3, 2026UPXI
UPEXI, INC.
Award(A)Direct100K shares- - Feb 11, 2026COEP
Coeptis Therapeutics Holdings, Inc.
Exercise(M)Direct5.7K shares at avg. $10.56$60K - Feb 11, 2026COEP
Coeptis Therapeutics Holdings, Inc.
Award(A)Direct3.3K shares- - Dec 31, 2025MOBQ
Mobiquity Technologies, Inc.
Award(A)DirectCommon Stock Options
250K shares- - Nov 20, 2025UPXI
UPEXI, INC.
Purchase(P)Indirect50K shares at avg. $2.55$127K - Nov 17, 2025UPXI
UPEXI, INC.
Purchase(P)Indirect100K shares at avg. $2.81$281K - Nov 17, 2025UPXI
UPEXI, INC.
Purchase(P)Direct100K shares at avg. $2.65$265K - Sep 15, 2025MOBQ
Mobiquity Technologies, Inc.
Award(A)Direct25K shares at avg. $1.00$25K - Jul 16, 2025UPXI
UPEXI, INC.
Award(A)Direct50K shares- - Jul 16, 2025UPXI
UPEXI, INC.
Award(A)Direct150K shares- - Jul 11, 2025UPXI
UPEXI, INC.
Purchase(P)Direct20.2K shares at avg. $4.94$100K - Apr 17, 2025UPXI
UPEXI, INC.
Award(A)DirectOptions to buy common stock
35K shares- - Apr 17, 2025UPXI
UPEXI, INC.
Purchase(P)Direct241.2K shares at avg. $2.28$550K - Mar 4, 2025COEP
Coeptis Therapeutics Holdings, Inc.
Award(A)DirectNon-qualified Stock Options (right to buy)
5.7K shares- - Jan 17, 2025UPXI
UPEXI, INC.
Award(A)DirectOptions to buy common stock
25K shares- - Dec 30, 2024MOBQ
Mobiquity Technologies, Inc.
In-the-Money(X)Direct420K shares at avg. $0.50$210K - Oct 8, 2024MOBQ
Mobiquity Technologies, Inc.
Award(A)DirectCommon Stock Options
250K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 3, 2026 |  UPXI UPEXI, INC. | Award(A) | 100,000 | - | $0 | Direct |
| Feb 11, 2026 |  COEP Coeptis Therapeutics Holdings, Inc. | Exercise(M) | 5,700 | $10.56 | $60,192 | Direct |
| Feb 11, 2026 | COEP Coeptis Therapeutics Holdings, Inc. | Award(A) | 3,250 | - | $0 | Direct |
| Dec 31, 2025 |  MOBQ Mobiquity Technologies, Inc. | Award(A) Common Stock Options | 250,000 | - | - | Direct |
| Nov 20, 2025 | UPXI UPEXI, INC. | Purchase(P) | 50,000 | $2.55 | $127,500 | Indirect |
| Nov 17, 2025 | UPXI UPEXI, INC. | Purchase(P) | 100,000 | $2.81 | $281,000 | Indirect |
| Nov 17, 2025 | UPXI UPEXI, INC. | Purchase(P) | 100,000 | $2.65 | $265,000 | Direct |
| Sep 15, 2025 | MOBQ Mobiquity Technologies, Inc. | Award(A) | 25,000 | $1.00 | $25,000 | Direct |
| Jul 16, 2025 | UPXI UPEXI, INC. | Award(A) | 50,000 | - | - | Direct |
| Jul 16, 2025 | UPXI UPEXI, INC. | Award(A) | 150,000 | - | - | Direct |
| Jul 11, 2025 | UPXI UPEXI, INC. | Purchase(P) | 20,243 | $4.94 | $100,000 | Direct |
| Apr 17, 2025 | UPXI UPEXI, INC. | Award(A) Options to buy common stock | 35,000 | - | - | Direct |
| Apr 17, 2025 | UPXI UPEXI, INC. | Purchase(P) | 241,229 | $2.28 | $550,002 | Direct |
| Mar 4, 2025 | COEP Coeptis Therapeutics Holdings, Inc. | Award(A) Non-qualified Stock Options (right to buy) | 5,700 | - | - | Direct |
| Jan 17, 2025 | UPXI UPEXI, INC. | Award(A) Options to buy common stock | 25,000 | - | - | Direct |
| Dec 30, 2024 | MOBQ Mobiquity Technologies, Inc. | In-the-Money(X) | 420,000 | $0.50 | $210,000 | Direct |
| Oct 8, 2024 | MOBQ Mobiquity Technologies, Inc. | Award(A) Common Stock Options | 250,000 | - | - | Direct |
1-17 of 17 transactions
About Salkind Gene
Salkind Gene (SEC CIK 0001592481) files insider reports with the SEC as Director of UPEXI, INC. (UPXI), Director of Coeptis Therapeutics Holdings, Inc. (COEP) and Director of Mobiquity Technologies, Inc. (MOBQ).
Signal8 holds 11 ownership filings by Salkind Gene, all Form 4s, filed between Oct 21, 2024 and Jul 20, 2026. Those filings report 17 transactions, from Oct 8, 2024 to Jul 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Salkind Gene's filings is in TAMPA, FL.
Recent filings by Salkind Gene
- Jul 3, 2026: Grant or award of UPXI shares (Form 4, code A).
- Feb 11, 2026: Option exercise of COEP shares (Form 4, code M).
- Feb 11, 2026: Grant or award of COEP shares (Form 4, code A).
- Dec 31, 2025: Grant or award of MOBQ derivative securities (Form 4, code A).
- Nov 20, 2025: Open-market purchase of UPXI shares (Form 4, code P).
Other insiders filing for UPEXI, INC. (UPXI)
- Dugan Lawrence, Director
- Rudick Brian Benjamin, Chief Strategy Officer
- MARSHALL ALLAN, Chief Executive Officer
- Norstrud Andrew James, Chief Financial Officer
- Williams Thomas Charles, Director